These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9312218)

  • 1. [Determination of flunisolide and its principal hydrolytic metabolite in urine and plasma by LC-NICI-MS with a particle beam interface].
    Rauli S; Del Puppo M; De Angelis L; Galli Kienle M
    Boll Chim Farm; 1997 Apr; 136(4):308-15. PubMed ID: 9312218
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation.
    Möllmann H; Derendorf H; Barth J; Meibohm B; Wagner M; Krieg M; Weisser H; Knöller J; Möllmann A; Hochhaus G
    J Clin Pharmacol; 1997 Oct; 37(10):893-903. PubMed ID: 9505980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers.
    Nolting A; Sista S; Abramowitz W
    Biopharm Drug Dispos; 2001 Dec; 22(9):373-82. PubMed ID: 11870676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of flunisolide in human plasma.
    Nerenberg C; Matin SB
    J Pharm Sci; 1981 Aug; 70(8):900-4. PubMed ID: 7310659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HPLC radiometric assay to quantitate flunisolide metabolites in body fluids.
    Chu NI; Teitelbaum PJ; Chaplin MD
    Proc West Pharmacol Soc; 1981; 24():281-4. PubMed ID: 7255469
    [No Abstract]   [Full Text] [Related]  

  • 6. Flunisolide metabolism and dynamics of a metabolite.
    Chaplin MD; Rooks W; Swenson EW; Cooper WC; Nerenberg C; Chu NI
    Clin Pharmacol Ther; 1980 Mar; 27(3):402-13. PubMed ID: 7357797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent sex difference in the metabolism of flunisolide in rats.
    Chaplin MD; Hama KM; Chu NI
    Proc West Pharmacol Soc; 1981; 24():285-7. PubMed ID: 7255470
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and identification of an oxidatively defluorinated metabolite of flunisolide in man.
    Tökés L; Cho D; Maddox ML; Chaplin MD; Chu NI
    Drug Metab Dispos; 1981; 9(5):485-6. PubMed ID: 6117452
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide.
    Nolting A; Sista S; Abramowitz W
    J Pharm Sci; 2002 Feb; 91(2):424-32. PubMed ID: 11835202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
    J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of glucocorticoids to human nasal tissue in vitro.
    Esmailpour N; Högger P; Rohdewald P
    Int Arch Allergy Immunol; 2000 Jun; 122(2):151-4. PubMed ID: 10878494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmilide--dosage aerosol].
    Mally M
    Wien Klin Wochenschr; 1994; 106(5):146-50. PubMed ID: 8171872
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro studies on the binding of cloprednol to human plasma proteins.
    Tomlinson RV; Runkel R; Chaplin MD; Bowen L; Kanagy J; Chu N
    J Steroid Biochem; 1982 Jan; 16(1):75-80. PubMed ID: 7062742
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration.
    Dickens GR; Wermeling DP; Matheny CJ; John W; Abramowitz W; Sista SM; Foster T; Choudhury S
    Ann Allergy Asthma Immunol; 2000 May; 84(5):528-32. PubMed ID: 10831007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose proportionality study of flunisolide hydrofluoroalkane.
    Nolting A; Abramowitz W
    Allergy Asthma Proc; 2002; 23(5):311-8. PubMed ID: 12476540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doses per container of flunisolide.
    Bodenheimer S
    Am Fam Physician; 1991 Aug; 44(2):400. PubMed ID: 1858600
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of flunisolide plasma levels to eosinopenic response in humans.
    Chaplin MD; Cooper WC; Segre EJ; Oren J; Jones RE; Nerenberg C
    J Allergy Clin Immunol; 1980 Jun; 65(6):445-453. PubMed ID: 7372965
    [No Abstract]   [Full Text] [Related]  

  • 18. [Absence of pharmacokinetic interference between flunisolide and salbutamol].
    Lampa E; Cazzola M; Brita G; Del Gaudio F; Marmo E; Fano M; Bugada G; Montagna D; Catania M; Bernareggi V
    Boll Chim Farm; 1984 Jul; 123(7):330-5. PubMed ID: 6518091
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism for the oxidative defluorination of flunisolide.
    Teitelbaum PJ; Chu NI; Cho D; Tökés L; Patterson JW; Wagner PJ; Chaplin MD
    J Pharmacol Exp Ther; 1981 Jul; 218(1):16-22. PubMed ID: 7241375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flunisolide (Syntaris) and beclomethasone (Beconase) in the treatment of non-allergic eosinophilic rhinitis.
    Zawisza E; Samoliński B; Swierczyński Z
    Pneumonol Alergol Pol; 1992; 60 Suppl 2():153-5. PubMed ID: 1305497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.